Press releases
- Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
- Edwards Lifesciences to Sell Critical Care to BD
- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
More ▼
Key statistics
As of last trade Edwards Lifesciences Corp (EWLS:VIE) traded at 84.32, -4.49% below its 52-week high of 88.28, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 84.32 |
---|---|
High | 84.32 |
Low | 84.32 |
Bid | 84.00 |
Offer | 84.67 |
Previous close | 85.35 |
Average volume | 0.00 |
---|---|
Shares outstanding | 602.60m |
Free float | 597.19m |
P/E (TTM) | 39.21 |
Market cap | 54.98bn USD |
EPS (TTM) | 2.33 USD |
Data delayed at least 15 minutes, as of Jul 02 2024.
More ▼